已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Correlative effect between sac regression and patient longevity following endovascular solution for abdominal aortic aneurysms: an international analysis

医学 外科 主动脉修补术 回归分析 动脉瘤 统计 数学
作者
Matti Jubouri,Abdelaziz O Surkhi,Sven Z. C. P. Tan,Damian Miles Bailey,Ian Michael Williams,Mohamad Bashir
出处
期刊:Asian Cardiovascular and Thoracic Annals [SAGE Publishing]
卷期号:31 (7): 557-564 被引量:2
标识
DOI:10.1177/02184923221129983
摘要

Introduction Since the introduction of endovascular aortic repair (EVAR) it has become the mainstay treatment for abdominal aortic aneurysms. Several EVAR devices exist commercially, yet, the Terumo Aortic Fenestrated Anaconda™ endograft has demonstrated outstanding results. Evidence in the literature suggests that sac regression could be linked to patient survival and longevity. The main scope of this study is to evaluate sac regression and survival achieved using the Fenestrated Anaconda™ endograft and to discuss relevant literature. Materials and methods The current study represents a nine-year cross-sectional international analysis of custom-made Fenestrated Anaconda™ device. For the statistical analysis, SPSS 28 for Windows and R were utilised. Pearson chi-square analysis was used to assess differences in cumulative distribution frequencies between select variables. Statistical significance for all two-tailed tests was set at p < 0.05. Results A total of 5,058 patients received the Fenestrated Anaconda™ in this study, either due to unsuitable/complex anatomy for competitor devices ( n = 3,891) or based on surgeon preference ( n = 1,167). A sac regression of 0–30% was observed in 4,772 (94.3%) over the first four years post-EVAR. Here, 99.6% of patients receiving the Fenestrated Anaconda™ due to unsuitable/complex anatomy for competitor devices and 76.8% based on surgeon preference had 0–30% sac regression. During years 5–9 of follow-up, all patients had 20–45% sac regression. Patient survival during the first six years post-EVAR was 100% but dropped to 77.1% in years 7–9. Survival differed between categorical patient subsets based on the indication. Discussion The Fenestrated Anaconda™ has been proven to be a highly effective EVAR endograft. Evidence in the literature clearly demonstrates that sac regression is an accurate prognostic factor for patient survival and longevity.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
老才完成签到 ,获得积分0
2秒前
junio完成签到 ,获得积分10
2秒前
流云发布了新的文献求助10
3秒前
4秒前
科研通AI6.2的应助被大观天下采纳,获得10
4秒前
丘比特的应助被flyinglin采纳,获得30
4秒前
Ava的应助被flyinglin采纳,获得30
4秒前
上官若男的应助被flyinglin采纳,获得50
4秒前
酷波er的应助被flyinglin采纳,获得30
4秒前
SciGPT的应助被flyinglin采纳,获得30
5秒前
5秒前
充电宝的应助被flyinglin采纳,获得30
5秒前
Ruo完成签到,获得积分10
5秒前
大个的应助被lee采纳,获得20
7秒前
hyelachan完成签到,获得积分20
7秒前
Ambition发布了新的文献求助10
8秒前
yu完成签到,获得积分20
8秒前
9秒前
9秒前
Echo关注了科研通微信公众号
10秒前
慕青的应助被flyinglin采纳,获得10
12秒前
搜集达人的应助被flyinglin采纳,获得10
12秒前
脑洞疼的应助被flyinglin采纳,获得10
12秒前
12秒前
molihuakai的应助被flyinglin采纳,获得10
13秒前
ding的应助被flyinglin采纳,获得10
13秒前
jjhmh123的应助被flyinglin采纳,获得10
13秒前
jjhmh123的应助被flyinglin采纳,获得10
13秒前
jjhmh123的应助被flyinglin采纳,获得10
13秒前
bkagyin的应助被flyinglin采纳,获得10
14秒前
杨小杨完成签到 ,获得积分10
14秒前
No1完成签到,获得积分10
15秒前
拍个月亮发布了新的文献求助10
15秒前
15秒前
从容棉花糖完成签到,获得积分10
15秒前
研友_Z7gV2Z完成签到,获得积分10
15秒前
在水一方的应助被mengloo采纳,获得10
18秒前
haoyunlai关注了科研通微信公众号
18秒前
科研通AI6.4的应助被呆萌幻竹采纳,获得10
20秒前
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1080
Encyclopedia of Modern Artificial Intelligence 1000
Особенности технологий и методов информационно-психологических войн СССР с Великобританией и США в период 1939-1953 гг 1000
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Cellulose and Cellulose Derivatives: Synthesis, Modification and Applications 600
Entre Praga y Madrid : los contactos checoslovaco-españoles (1948-1977) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8146721
求助须知:如何正确求助?哪些是违规求助? 9545249
关于积分的说明 21668108
捐赠科研通 7732981
什么是DOI,文献DOI怎么找? 3423139
关于科研通互助平台的介绍 2548169
邀请新用户注册赠送积分活动 2466163